Skip to main content
Press Release

Cellics Announces the Receipt of CARB-X Award of Up to US$15 Million

By October 21, 2021November 4th, 2022No Comments

Cellics announced today that it has received a CARB-X Award of up to US$15 Million to develop a new treatment for sepsis caused by drug-resistant Gram-positive and Gram-negative bacteria. The award will allow Cellics to advance its highly versatile platform to treat not only sepsis but other conditions with unmet medical needs such as post CAR-T Cytokine Release Syndrome (CRS) and COVID-19.

– CARB-X News Link

– UCSD News Link